Jens Rueter, M.D.
Chief Medical Officer, JAX; Medical Director, MCGI
Chief Medical Officer who provides direction, leadership and strategy for JAX's translational and clinical research activities and clinically-oriented operations.
The JAX Cancer Center
jens.rueter@jax.org
Jens Rueter, M.D. is the Chief Medical Officer of The Jackson Laboratory and Medical Director for the Maine Cancer Genomics Initiative. Rueter is a practicing hematologist/oncologist in Maine and has served as Medical Director for MCGI since its inception in 2016. In 2021, Rueter was named JAX's first CMO and serves as the institution's principal medical advisor.
Rueter came to JAX from Eastern Maine Medical Center Cancer Care (EMMC) in Brewer, Maine, where he was Medical Director for EMMC's Translational Oncology Program and the EMMC Biobank. He has been on staff at Northern Light Eastern Maine Medical Center since 2010, and a member of the JAX adjunct faculty since 2012. Prior to joining JAX, Rueter collaborated with several JAX investigators and technicians on developing new approaches to treating cancers while advancing translational research at EMMC. After graduating from medical school in Berlin, Germany, Rueter completed his residency in internal medicine at Tulane University and fellowship training in hematology/oncology at the University of Pennsylvania.
Blog PostJanuary 09, 2023
MCGI: Meet the team
Learn more about the JAX MCGI team, including roles and fun facts.
Featured ArticleJune 28, 2022
JAX Genomic Medicine is increasing the precision of brain cancer diagnoses
The new technique of methylome profiling, now available from The Jackson Laboratory, provides more precise tumor classification for cancers of the central nervous system (CNS).
Cancer/Tumors
Genetic Tools
mcgi
Press ReleaseOctober 14, 2021
JAX appoints first ever Chief Medical Officer, Jens Rueter
Jens Rueter, M.D. has been appointed the first ever chief medical officer of The Jackson Laboratory. Rueter is a practicing physician in Maine and has served as medical director of JAX's Maine Cancer Genomics Initiative (MCGI) for the past five years.
Press ReleaseDecember 02, 2020
JAX to expand advanced cancer clinical trial
JAX's Maine Cancer Genomics Initiative joins nationwide TAPUR Study, providing access to targeted cancer therapies for rural population.
JAX participates in A Day of Hope for Maines cancer fighters
Eight team members who make up JAX's MCGI recently attended MaineGeneral's annual Day of Hope Event at the Augusta Civic Center.
Search MagazineOctober 19, 2021
Five ways scientists are taking the fight to cancer
In this article, we examine the different ways cancer escalates the conflicts within our bodies, and how scientists are leveraging the incredible power of genetics and genomics to disarm it.
Search MagazineJune 29, 2021
When kids get cancer
The Maine Cancer Genomics Initiative is now working with pediatric oncologists to bring precision treatment approaches to young people with cancers.
Gliomas-Glioblastomas
Maine Cancer Genomics Initiative (MCGI) Forum
The Maine Cancer Genomics Initiative Forum brings together the oncology community to provide updates on new and exciting...
2023 MCGI Forum
Building Bridges through Genomic Medicine